GPM Reminds Investors of the September 12 Deadline in the Class Action Lawsuit Against Stericycle, Inc.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the September 12, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the “Class”) of investors who purchased Stericycle, Inc. ("Stericycle" or the "Company") (NASDAQ: SRCL) securities between February 7, 2013 and April 28, 2016, inclusive (the “Class Period”). Stericycle investors have until September 12, 2016 to file a lead plaintiff motion.

On September 9, 2015, Stericycle announced a public offering of 7,000,000 depositary shares at $100.00 per share. Shortly thereafter, on October 22, 2015, Stericycle issued its financial results for the 2015 third quarter and year to date, these results fell below expectations, with the Company reporting a revenue for the third quarter of $718.6 million. In a conference call, CEO Charlie Alutto noted that the “slowdown which we saw accelerate in the third quarter is going to actually get worse in fourth quarter and then level off in 2016.” Upon this news, shares of Stericycle dropped more than 12 percent thereby damaging investors.

The complaint filed in this action alleges that the defendants failed to adequately disclose to investors the disappointing growth rates and future revenues, and upon disclosure of the Company’s actual financial health Stericycle shares declined sharply in value.

If you purchased Stericycle shares, you may move the Court no later than September 12, 2016 to request appointment as lead plaintiff. To be a member of the class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160729005792/en/